RCM
BLCM

RA Capital Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

RA Capital Management’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-31,570
Closed -$4.59M – 50
2015
Q3 		$4.59M Sell
31,570
-71,070
-69% -$13M 0.66% 35
2015
Q2 		$21.8M Hold
102,640
– – 2.2% 16
2015
Q1 		$23.8M Hold
102,640
– – 2.36% 14
2014
Q4 		$9.34M Buy
+102,640
New +$22M 1% 24

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RA Capital Management's BLCM Position: Q4 2015 in Review

RA Capital Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2015, closing a stake of 31,570 shares — an estimated $4.59M sold.

RA Capital Management first reported a position in BLCM in Q4 2014 and held it in 4 quarters. The position peaked at $23.8M in Q1 2015. 81 funds tracked by Wall St. Rank hold BLCM as of Q4 2015.

  • RA Capital Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • RA Capital Management sold 31,570 Bellicum Pharmaceuticals, Inc. shares in Q4 2015, an estimated $4.59M.
  • RA Capital Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 4 quarters.
  • RA Capital Management's Bellicum Pharmaceuticals, Inc. position peaked at $23.8M in Q1 2015.
  • 81 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2015.

Based on RA Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.